Rare Zoonotic Pulmonary Infection in Humans: Bordetella bronchiseptica - A Case report
Main Article Content
Abstract
Bordetella bronchiseptica is a zoonotic Gram-negative coccobacillus that commonly causes respiratory infections in animals but is rarely implicated in human disease. The patient presented with recurrent hemoptysis for one month and a history of two previous presentations of pulmonary tuberculosis, treated with antitubercular therapy. In view of persistent symptoms, the patient was evaluated for other causes of chronic pulmonary infection. Differential diagnosis, including chronic pulmonary aspergillosis, non-tuberculous mycobacterial infection and subacute invasive aspergillosis was considered and ruled out by appropriate investigations. Microbiological culture of respiratory samples, bronchoalveolar lavage (BAL), revealed non-lactose fermenting colonies, and Gram staining showed small, gram-negative coccobacilli and the isolate was identified as Bordetella bronchiseptica by MALDI-TOF mass spectrometry. The patient had a history of close exposure to dogs, suggesting zoonotic transmission. In the absence of established treatment guidelines and CLSI-defined breakpoints for Bordetella bronchiseptica, treatment was guided by antimicrobial susceptibility testing with results interpreted using surrogate criteria for non-fermenting gram-negative bacilli. The patient showed clinical improvement with cefoperazone–sulbactam followed by cotrimoxazole. This case highlights the importance of considering rare zoonotic pathogens in patients with underlying lung disease and the role of advanced diagnostic techniques in accurate identification.
Article Details
Section
How to Cite
References
1. Loong SK, et al. Human infection with Bordetella bronchiseptica: an emerging zoonosis. Int J Infect Dis. 2016;45:47–55.
2. Clements J, McGrath C, McAllister C. Bordetella bronchiseptica pneumonia: beware of the dog! BMJ Case Rep. 2018;2018:bcr2018224588.
3. Register KB, Sukumar N, Palavecino EL, Rubin BK. Bordetella bronchiseptica infections in humans: a review. J Clin Microbiol. 2012;50(10):3151–3157.
4. García-de-la-Fuente C, et al. Bordetella bronchiseptica pneumonia in humans: case report and literature review. Respir Med Case Rep. 2015;16:123–125.
5. Yacoub AT, et al. Bordetella bronchiseptica in immunocompromised hosts: a case series and review. Infection. 2014;42(2):349–357.
6. Wernli D, Emonet S, Schrenzel J, Harbarth S. Bordetella bronchiseptica infections in humans: risk factors and clinical outcomes. Infect Dis Clin Pract. 2011;19(2):123–128.
7. Duggal SD, Chugh TD. Bordetella bronchiseptica infections in humans: a review of cases and risk factors. J Infect Dev Ctries. 2008;2(5):329–334.
8. Tatti KM, Sparks KN, Boney KO, Tondella ML. Identification of Bordetella species using MALDI-TOF mass spectrometry. J Clin Microbiol. 2013;51(3):809–814.
9. Seng P, Drancourt M, Gouriet F, et al. Routine identification of bacteria by MALDI-TOF mass spectrometry. Clin Infect Dis. 2009;49(4):543–551.
10. Murray PR, Rosenthal KS, Pfaller MA. Medical Microbiology. 8th ed. Elsevier; 2016.
11. Sauret JM, et al. Bordetella bronchiseptica pneumonia: clinical features and outcomes. Respir Med. 2020;170:106060.
12. Weingarten RA, et al. Clinical and microbiological features of Bordetella bronchiseptica infections. Diagn Microbiol Infect Dis. 2015;82(4):322–326.
13. Ner Z, et al. Bordetella bronchiseptica infection in cystic fibrosis: case series and review. Clin Respir J. 2014;8(4):469–474.
14. Martí C, et al. Bordetella bronchiseptica infection in humans: a systematic review. Eur J Clin Microbiol Infect Dis. 2018;37(7):1221–1230.
15. Garcia-de-la-Fuente C, et al. Microbiological and clinical aspects of respiratory infections associated with Bordetella bronchiseptica. Diagn Microbiol Infect Dis. 2015;82(1):20–25.
16. Multifocal pneumonia caused by Bordetella bronchiseptica: a case study. IDCases. 2024;35:e04120.
17. Shah MM, Odoyo E, Larson PS. Human infection due to Bordetella bronchiseptica: a case report and literature review. J Infect Public Health. 2021;14(9):1234–1237.
18. Kadlec K, Schwarz S. Antimicrobial Resistance in Bordetella bronchiseptica. Microbiology Spectrum. 2018;6(4): ARBA-0024-2017.
19. Riccardi N, et al. Why don’t we talk about tuberculosis stewardship? Clin Microbiol Infect. 2025.
20. Clinically diagnosed tuberculosis and mortality in high burden settings: systematic review and meta-analysis. 2025.
21. Diagnostic stewardship aiming at expectorated or induced sputum promotes microbial diagnosis. BMC Infect Dis. 2022.
22. Dik JWH, Poelman R, Friedrich AW, et al. Principles of diagnostic stewardship: a practical guide from the SHEA Diagnostic Stewardship Task Force. Infect Control Hosp Epidemiol. 2023.